Strs Ohio Acquires 6,196 Shares of STERIS plc $STE

Strs Ohio lifted its holdings in shares of STERIS plc (NYSE:STE) by 9.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 71,748 shares of the medical equipment provider’s stock after buying an additional 6,196 shares during the quarter. Strs Ohio’s holdings in STERIS were worth $15,866,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Board of the Pension Protection Fund bought a new stake in STERIS during the 4th quarter valued at $25,000. Harbor Investment Advisory LLC boosted its holdings in shares of STERIS by 115.4% in the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 60 shares during the period. Activest Wealth Management grew its position in shares of STERIS by 423.8% in the fourth quarter. Activest Wealth Management now owns 110 shares of the medical equipment provider’s stock valued at $28,000 after purchasing an additional 89 shares in the last quarter. Measured Wealth Private Client Group LLC purchased a new position in shares of STERIS in the fourth quarter valued at $28,000. Finally, Geneos Wealth Management Inc. lifted its holdings in STERIS by 416.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 104 shares in the last quarter. 94.69% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have commented on STE shares. KeyCorp cut their target price on STERIS from $291.00 to $269.00 and set an “overweight” rating for the company in a research note on Wednesday, May 13th. Piper Sandler reaffirmed an “overweight” rating and set a $270.00 price objective on shares of STERIS in a research note on Thursday, May 21st. Weiss Ratings lowered shares of STERIS from a “hold (c+)” rating to a “hold (c)” rating in a report on Wednesday, May 27th. Finally, Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 6th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, STERIS currently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insider Activity

In related news, VP John Adam Zangerle sold 1,419 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $209.28, for a total transaction of $296,968.32. Following the transaction, the vice president owned 35,259 shares of the company’s stock, valued at approximately $7,379,003.52. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Richard C. Breeden sold 1,481 shares of STERIS stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $209.51, for a total transaction of $310,284.31. Following the completion of the transaction, the director owned 38,964 shares in the company, valued at approximately $8,163,347.64. The trade was a 3.66% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 7,328 shares of company stock valued at $1,554,051. Corporate insiders own 1.12% of the company’s stock.

STERIS Stock Performance

NYSE:STE opened at $217.94 on Friday. The stock has a market cap of $21.24 billion, a P/E ratio of 27.48 and a beta of 0.92. The company has a quick ratio of 1.54, a current ratio of 2.09 and a debt-to-equity ratio of 0.25. The business’s 50-day moving average price is $211.91 and its two-hundred day moving average price is $231.83. STERIS plc has a twelve month low of $195.14 and a twelve month high of $269.44.

STERIS (NYSE:STE) last announced its earnings results on Monday, May 11th. The medical equipment provider reported $2.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.86 by ($0.03). The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.59 billion. STERIS had a return on equity of 14.15% and a net margin of 13.18%.The firm’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.74 earnings per share. STERIS has set its FY 2027 guidance at 11.100-11.300 EPS. As a group, equities analysts predict that STERIS plc will post 11.18 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 26th. Stockholders of record on Monday, June 8th were issued a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Monday, June 8th. STERIS’s payout ratio is presently 31.78%.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.